搜尋結果
13 小時前 · Metformin use lowers the risk for gout by 32% in individuals with prediabetes; however, the treatment doesn't change serum urate or C-reactive protein levels. Individuals with prediabetes not only ...
1 天前 · 2016年10月14日讯 10月11日，厦门大学生命科学学院林圣彩（Sheng-Cai Lin）教授课题组在Cell Metabolism上发表了题为“Metformin Activates AMPK through the Lysosomal Pathway”的论文，揭开了二甲双胍降血糖作用背后的机制，并且找到了该药抗癌作用相关的
3 天前 · 近年来，许多研究显示，二甲双胍除了具有降血糖作用外，在临床前模型中一再被证明可以抗衰老，并与较低的死亡率有关，因此二甲双胍也被人们称为「神药」。然而，二甲双胍对心血管的影响一直是医学界争论的话题。
13 小時前 · The unexpected potential of metformin in cancer prevention was highlighted when researchers identified a correlation between its use and a reduced risk of myeloproliferative neoplasms (MPNs) – a rare type of blood cancer that can progress to acute leukaemia. MPNs occur when the body overproduces red blood cells, white blood cells, or ...
4 天前 · Metformin use was found to significantly lower the likelihood of developing myeloproliferative neoplasms (MPN), which may also be useful in preventing the development of additional cancers, according to findings from a meta-analysis published in Blood Advances.
1 天前 · Metformin use was compared among cases with MPN and an age- and sex-matched control group from the Danish general population (3,816 cases and 19,080 controls). The researchers found that 7.0 and 8.2 percent of cases and controls were categorized as ever-users of metformin, respectively (odds ratio [OR] for MPN, 0.84; adjusted OR for MPN, 0.70).
1 天前 · People who use metformin are less likely to develop a group of rare blood cancers over time. The corresponding study was published in Blood Advances. Metformin is a drug used to treat high blood sugar in people with type 2 diabetes. Studies suggest that it may hold potential against cancer- both as a preventative agent and as a therapeutic when used alongside immunotherapy, although further ...
